- Home
- INTS vs CENN Comparison
INTS vs CENN Comparison
Compare INTS & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- CENN
- Stock Information
- Founded
- INTS 2012
- CENN 2013
- Country
- INTS United States
- CENN United States
- Employees
- INTS N/A
- CENN N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- CENN Auto Manufacturing
- Sector
- INTS Health Care
- CENN Consumer Discretionary
- Exchange
- INTS Nasdaq
- CENN Nasdaq
- Market Cap
- INTS 33.4M
- CENN 32.4M
- IPO Year
- INTS 2023
- CENN N/A
- Fundamental
- Price
- INTS $2.23
- CENN $0.84
- Analyst Decision
- INTS Strong Buy
- CENN
- Analyst Count
- INTS 3
- CENN 0
- Target Price
- INTS $8.50
- CENN N/A
- AVG Volume (30 Days)
- INTS 26.6K
- CENN 186.5K
- Earning Date
- INTS 03-13-2025
- CENN 03-04-2025
- Dividend Yield
- INTS N/A
- CENN N/A
- EPS Growth
- INTS N/A
- CENN N/A
- EPS
- INTS N/A
- CENN N/A
- Revenue
- INTS N/A
- CENN $37,052,841.00
- Revenue This Year
- INTS N/A
- CENN N/A
- Revenue Next Year
- INTS N/A
- CENN N/A
- P/E Ratio
- INTS N/A
- CENN N/A
- Revenue Growth
- INTS N/A
- CENN 142.48
- 52 Week Low
- INTS $1.50
- CENN $0.80
- 52 Week High
- INTS $5.94
- CENN $2.30
- Technical
- Relative Strength Index (RSI)
- INTS 49.26
- CENN 23.11
- Support Level
- INTS $1.84
- CENN $0.80
- Resistance Level
- INTS $2.27
- CENN $1.02
- Average True Range (ATR)
- INTS 0.28
- CENN 0.05
- MACD
- INTS -0.01
- CENN -0.02
- Stochastic Oscillator
- INTS 56.36
- CENN 16.19
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles. Its vehicles include Metro, Logistar 400, Logistar 200, Neibor 200, and ORV. The company's geographical segments include Europe, America, and Asia.